Dr. Tony George is Chief of the Addictions Division, Clinician Scientist in the Campbell Family Mental Health Research Institute and Head of the Biobehavioural Addictions and Concurrent Disorders Research Laboratory (BACDRL) at CAMH. He is also Professor and Co-Director of the Division of Brain and Therapeutics in the Department of Psychiatry at the University of Toronto.
He has over 220 peer-reviewed publications, book chapters and other reports, and is a Fellow of the American College of Neuropsychopharmacology (ACNP). He is Deputy Editor of ACNP’s journal Neuropsychopharmacology, and contributed the chapter on Nicotine and Tobacco to Cecil Textbook of Medicine in the 2011 and 2015 editions. He is a member of the Scientific Advisory Council of the Canadian Council on Substance Abuse (CCSA), co-editing its report on Cannabis and Youth in 2015.
Dr. George completed his undergraduate and medical school training at Dalhousie University in Halifax, Nova Scotia, graduating with his MD degree in 1992, and then completed psychiatry residency training (1992-96) and a fellowship in translational neuroscience (1996-98) at the Yale University School of Medicine in New Haven, Connecticut.
From 2008 to 2012, he was Clinical Director of the CAMH Schizophrenia Program, and from 2012 to 2016, he was Chief of the Schizophrenia Division and Medical Director of the Complex Mental Illness Program at CAMH. He was also the inaugural holder of the Chair in Addiction Psychiatry at the University of Toronto from 2006 to 2012.
Areas of Research
Dr. George directs a program of research focused on understanding the biological basis of addiction comorbidity in serious mental illness, with a focus on tobacco and cannabis use in schizophrenia. His research is supported by the Canadian Institutes of Health Research (CIHR), the National Institutes of Health (NIH) and Canada Foundation for Innovation (CFI).
View Dr. George's publications on PubMed.